Determinants of survival in patients with ventricular tachyarrhythmias.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 6855814)

Published in N Engl J Med on June 16, 1983

Authors

C D Swerdlow, R A Winkle, J W Mason

Articles citing this

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Mapping and ablation of ventricular tachycardia with the aid of a non-contact mapping system. Heart (1999) 1.23

Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability. J Clin Invest (1985) 1.06

Monophasic action potential recordings during acute changes in ventricular loading induced by the Valsalva manoeuvre. Br Heart J (1992) 0.92

Diagnosis and management of ventricular tachycardia. Postgrad Med J (1992) 0.87

Diagnosis of ventricular tachycardia: a clinical algorithm. Br Med J (Clin Res Ed) (1985) 0.83

Who needs ventricular stimulation studies? Br Heart J (1994) 0.81

Supraventricular tachycardias. Br Med J (Clin Res Ed) (1984) 0.79

Amiodarone in long term prophylaxis. Drugs (1991) 0.79

Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias. Br Heart J (1995) 0.78

Treatment of malignant ventricular arrhythmias with the automatic implantable cardioverter defibrillator. Ann Surg (1989) 0.78

Electrophysiological testing after acute myocardial infarction. Br Med J (Clin Res Ed) (1986) 0.77

Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function. Heart (1997) 0.77

Recent trends in the management of life-threatening ventricular arrhythmias. West J Med (1984) 0.75

Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System. Tex Heart Inst J (1993) 0.75

Exercise in electrocardiography. Can Vet J (1991) 0.75

Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs. Br Heart J (1993) 0.75

A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator. CMAJ (1987) 0.75

Digitized QT dispersion by the Valsalva maneuver in hypertensive patients. Korean J Intern Med (2005) 0.75

Cardiac arrhythmias: theory and practice. Br Med J (Clin Res Ed) (1985) 0.75

Interaction between ventricular loading and repolarisation: relevance to arrhythmogenesis. Br Heart J (1992) 0.75

Recurrent ventricular tachycardia. Br Med J (Clin Res Ed) (1985) 0.75

The automatic implantable cardioverter/defibrillator for a life threatening arrhythmia in a case of post-partum cardiomyopathy. Postgrad Med J (1989) 0.75

Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol. Br Heart J (1990) 0.75

Long-term surgical results in sudden death syndrome associated with cardiac dysfunction after myocardial infarction. Ann Surg (1992) 0.75

Amiodarone: maximising survival benefit with empiric or guided therapy. J Interv Card Electrophysiol (2000) 0.75

Electrophysiologic evaluation of antiarrhythmic drugs. Cardiovasc Drugs Ther (1990) 0.75

Articles by these authors

Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56

Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol (1983) 3.01

Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39

Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation (1983) 2.24

Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17

Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07

Amiodarone. N Engl J Med (1987) 2.05

Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest (1988) 1.94

Advances in the understanding of myocarditis. Circulation (2001) 1.93

Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86

Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation (1997) 1.84

Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81

Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. (Committee on Pacemaker Implantation). Circulation (1991) 1.70

Arrhythmia discrimination using hemoglobin spectroscopy in humans. Heart Rhythm (2012) 1.68

Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep (1978) 1.68

Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol (1978) 1.68

A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med (1969) 1.65

Early anthracycline cardiotoxicity. Am J Med (1978) 1.63

Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63

Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry (1993) 1.56

Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol (1990) 1.54

Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52

Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation (1997) 1.49

Role of concentration-dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm (1979) 1.49

Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis. Am Heart J (1982) 1.48

The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45

Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol (1972) 1.42

Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol (1991) 1.42

Multicenter study of principles-based waveforms for external defibrillation. Ann Emerg Med (2001) 1.41

Inhibition of insulin secretion by infused epinephrine in rhesus monkeys. Endocrinology (1966) 1.39

Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35

Long-term tocainide therapy for ventricular arrhythmias. Circulation (1978) 1.35

Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med (1978) 1.34

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34

Effects of Physicochemical Factors and Bacterial Colony Morphotype on Association of Vibrio vulnificus with Hemocytes of Crassostrea virginica. Appl Environ Microbiol (1993) 1.32

Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation (1978) 1.28

Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J (1981) 1.27

Atypical atrioventricular node reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway. J Am Coll Cardiol (1997) 1.27

Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol (1972) 1.24

Viability of Vibrio vulnificus in Association with Hemocytes of the American Oyster (Crassostrea virginica). Appl Environ Microbiol (1995) 1.23

Continuing disability of patients with chest pain and normal coronary arteriograms. J Chronic Dis (1979) 1.21

ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography. A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography). J Am Coll Cardiol (2001) 1.20

Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med (1976) 1.20

Clinical pharmacology of propafenone. Circulation (1983) 1.19

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry (1993) 1.18

3'5' AMP and Ca 2+ in slime mold aggregation. Exp Cell Res (1971) 1.18

Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol (1977) 1.18

Current status of ambulatory electrocardiography. Am Heart J (1981) 1.18

ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: A report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the International Society for Holter and noninvasive electrocardiology. Circulation (2001) 1.17

Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide. Circulation (1976) 1.15

Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res (1984) 1.14

Endomyocardial biopsy: the balance of success and failure. Circulation (1985) 1.13

Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation (1993) 1.12

Amiodarone pulmonary toxicity and Professor Hounsfield. J Cardiovasc Electrophysiol (2001) 1.10

Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep (1978) 1.10

Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol (1977) 1.10

Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia. Circulation (1987) 1.08

A re-evaluation of the concept of "non-specificity" in stress theory. J Psychiatr Res (1971) 1.08

Endomyocardial biopsy. Ann Intern Med (1982) 1.07

Arrhythmias in patients with mitral valve prolapse. Circulation (1975) 1.06

Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery disease. Circulation (1977) 1.05

Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol (1982) 1.05

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review. Am J Cardiol (1982) 1.05

Autonomic nervous system and arrhythmias: studies in the transplanted denervated human heart. Cardiology (1976) 1.04

Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch (1983) 1.04

Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer (1982) 1.04

Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J (1981) 1.04

Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol (1987) 1.03

Mortality in patients with implanted automatic defibrillators. Ann Intern Med (1983) 1.01

A review of psychoendocrine research on the sympathetic-adrenal medullary system. Psychosom Med (1969) 1.00

Acebutolol disposition after intravenous administration. Clin Pharmacol Ther (1977) 0.99

Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis (1992) 0.99

Simultaneous echocardiographic phonocardiographic recordings at rest and during amyl nitrite administration in patients with mitral valve prolapse. Circulation (1975) 0.99

Renin, norepinephrine, and epinephrine responses to graded exercise. J Appl Physiol (1971) 0.99

Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation (1994) 0.98

The status of cardiac transplantation, 1975. Circulation (1975) 0.97

Dose-dependent acebutolol disposition after oral administration. Clin Pharmacol Ther (1978) 0.97

A psychoendocrine study of bereavement. II. Observations on the process of mourning in relation to adrenocortical function. Psychosom Med (1973) 0.96

A historical view of the stress field. J Human Stress (1975) 0.95

Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol (2001) 0.95

Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol (1978) 0.95

Life-threatening arrhythmias in the mitral valve prolapse syndrome. Am J Med (1976) 0.94

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology (1987) 0.94

Surgery for ventricular tachycardia: efficacy of left ventricular aneurysm resection compared with operation guided by electrical activation mapping. Circulation (1982) 0.94

Inflammatory myocardial diseases and cardiomyopathies. Am J Med (1997) 0.93

Infections after cardiac transplantation: relation to rejection therapy. Ann Intern Med (1976) 0.93

Suppression of premature ventricular contractions by acebutolol. Circulation (1977) 0.93

The Myocarditis Treatment Trial: design, methods and patients enrollment. Eur Heart J (1995) 0.92

Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1978) 0.92

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine. Am J Cardiol (1978) 0.91

Strategy in psychosomatic research. Psychosom Med (1971) 0.91

Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J Clin Endocrinol Metab (1993) 0.91

Clinical electrophysiologic effects of tocainide. Circulation (1978) 0.91